Retatrutide Supply Register

Sources, Formats, Prices

A scientist in a lab coat looks through a microscope while holding a pipette on a lab bench.

How to Interpret SKU and Catalog Codes on a Retatrutide Listing

A guide to reading SKU and catalog codes on retatrutide vendor listings, covering strength fields, vial size, batch identifiers, and how to decode them.

Reviewed by James Okafor, PharmD, clinical pharmacist ·

James Okafor, PharmD is a clinical pharmacist with 10 years of experience in academic hospital and specialty compounding environments, with expertise in peptide reconstitution, pharmaceutical stability, and storage protocols.

  • retatrutide
  • sourcing
  • catalog
  • sku

A SKU or catalog code on a retatrutide vendor listing is not a random string. It is usually a short, structured label that encodes strength, vial size, packaging batch, or an internal inventory reference, and learning to read it lets a buyer cross-check the code against the rest of the listing instead of taking the product title at face value. This piece walks through the segments that typically make up these codes, how to interpret them, and what mismatches between a code and the surrounding listing text can indicate.

What a catalog code is actually for

Retailers and research suppliers use SKU (stock-keeping unit) codes for the same reason any inventory system does: to distinguish one specific item variant from another in a database, on an invoice, and on a shipping label. For a retatrutide listing, that variant distinction usually maps to strength (how many milligrams are in the vial), pack size (single vial versus multi-vial set), and sometimes a batch or production run identifier. A code that looks like an arbitrary jumble of letters and numbers is, in most cases, a compressed version of information already stated elsewhere on the page.

Common segments found in a retatrutide catalog code

Codes differ by vendor, since there is no universal standard, but most fall into a handful of recognizable patterns:

  • Compound abbreviation: a short prefix such as “RTA” or “RT” standing in for retatrudide, used to group all listings of the same compound together in a catalog.
  • Strength field: a number tied to milligram content, such as “10” for a 10 mg vial or “5MG” written out more explicitly.
  • Pack or format field: a letter or short code indicating single-vial, multi-vial kit, or whether diluent is bundled with the vial.
  • Batch or lot segment: a date-based or sequential code (for example, a six-digit string reading YYMMDD) that ties the specific unit to a production or repackaging run.
  • Internal sequence number: a trailing number with no external meaning, used only so the vendor’s own system can tell two otherwise identical entries apart.

Not every listing includes all five segments. A smaller supplier might use only a strength field and a sequence number, while a larger catalog with multiple compounds and pack sizes tends to build longer, more structured codes.

Reading strength and vial size out of a code

The strength segment is the part worth checking most carefully, because it should agree with the milligram figure stated in the listing’s title and description. A code such as RTA-10-A1 breaking down as compound (RTA), strength (10, meaning 10 mg), and a pack designator (A1) is internally consistent if the listing text also says 10 mg. If the code says 10 but the listing description says 5 mg, that discrepancy is worth flagging to the seller before ordering, since it suggests either a copy-paste error in the listing or a code that was not updated when the product was relisted.

The table below shows how the same underlying vial might be represented across a few different vendor code conventions.

Code exampleCompound fieldStrength fieldPack/format fieldWhat it implies
RTA-10-A1RTA (retatrutide)10 (10 mg)A1 (single vial)Single 10 mg vial, first pack variant
RT10MG-SRT (retatrutide)10MG (10 mg)S (single)Single 10 mg vial, explicit strength label
240815-RT10240815 (batch date, Aug 15 2024)RT10 (retatrutide, 10 mg)Batch-first code, no separate pack field
RTA10-KIT3RTA (retatrutide)10 (10 mg)KIT3 (3-vial kit)Multi-vial kit of 10 mg vials

The exact letters and ordering vary by vendor, but strength and compound fields are the two segments most listings include in some form, since they are also the two fields a buyer is most likely to check against the product description.

Batch and lot identifiers, and why they matter separately from the SKU

A SKU describes the product variant; a batch or lot number describes the specific production run that vial came from. These are sometimes combined into a single catalog code and sometimes kept as two separate fields, one printed on the listing and another printed only on the vial label itself. A batch identifier is more useful for after-the-fact verification, since it is what a certificate of analysis is usually indexed against. A listing that only shows a SKU with no distinct batch or lot reference makes it harder to confirm, later, that the vial received matches a specific tested batch rather than just a general product line.

A worked example: matching a code to a reconstituted concentration

Catalog codes are also useful for double-checking math elsewhere on a listing. Suppose a listing displays the code RTA-15-A1 and states in its description that the vial contains 15 mg of lyophilized retatrutide. A buyer researching reconstitution volumes elsewhere might see a note that says “reconstitute with 3 mL of bacteriostatic water.” Concentration is calculated as the milligram amount divided by the milliliters of diluent added: 15 mg divided by 3 mL equals 5 mg/mL. Converting to a U-100 insulin syringe, where 1 mL equals 100 units, 5 mg/mL means every 20 units drawn corresponds to 1 mg (100 units divided by 5 mg/mL equals 20 units per mg). If the catalog code’s strength field says “15” but the reconstitution note on the same page describes a 3 mL draw meant for a 10 mg vial, the numbers stop lining up, and that inconsistency traces directly back to the strength field encoded in the SKU. Checking the code against the math is a fast way to catch that kind of listing error before it causes confusion later.

Why catalog codes vary so much between vendors

There is no shared registry or standard for how research chemical suppliers format SKUs, unlike pharmaceutical NDC codes, which follow a regulated structure. Each vendor builds its own catalog system, often shaped by whatever inventory or e-commerce software they use. This is one reason a code from one supplier’s listing has no meaning on another supplier’s site, even for what is nominally the same compound and strength. When comparing a retatrutide vial across two listings, treat each SKU as internal to that vendor’s system rather than as a portable identifier, similar to how this retatrutide vial is catalogued under its own reference scheme distinct from any third-party listing.

Red flags in a catalog code

A few patterns are worth treating as signals to look closer rather than proof of a problem on their own:

  • A strength field in the code that does not match the milligram amount stated in the listing description.
  • A code that changes between the product page and the invoice or shipping confirmation, with no explanation.
  • No batch or lot segment anywhere in the code or listing, leaving no way to tie a specific vial back to a tested run.
  • Codes that are reused across clearly different pack sizes or strengths, suggesting the vendor’s catalog is not well maintained.

None of these guarantees an issue with the product itself, but a code that does not agree with the rest of the listing is a reasonable reason to ask the seller a clarifying question before ordering.

Summary

A SKU or catalog code on a retatrutide listing is a compressed reference to compound, strength, pack size, and sometimes batch information, and reading it is mostly a matter of matching each segment back to what the listing states in plain text. Codes are not standardized across vendors, so a useful habit is checking internal consistency within a single listing rather than comparing codes across sellers. When the strength field, the description, and any reconstitution notes all agree, the code is functioning as intended: a shorthand for information that is already there, not a separate source of it.

Background sources referenced for general compound-class context include a 2021 review of the dual GIP/GLP-1 receptor agonist tirzepatide as a cardiometabolic therapeutic prospect, a 2024 review of dietary management strategies for patients on GLP-1 receptor agonists, a 2024 study of real-world persistence and adherence patterns for GLP-1 receptor agonists, and a 2022 study of GLP-1 receptor agonist effects on adipocyte tissue in animal models, each cited here for background on the compound class rather than for claims about listings or catalog practices.

← All articles